| Class 2 Device Recall Boston Scientific ROTAPRO | |
Date Initiated by Firm | November 08, 2021 |
Create Date | December 15, 2021 |
Recall Status1 |
Terminated 3 on May 02, 2023 |
Recall Number | Z-0381-2022 |
Recall Event ID |
89034 |
Product Classification |
Catheter, coronary, atherectomy - Product Code MCX
|
Product | Boston Scientific ROTAPRO, Rotational Atherectomy System Console, Model numbers H74939309010 (US) and H74939309030 (EU). |
Code Information |
US Serial numbers RP005005, RP005013, RP005017, RP005036, RP005039, and RP005040, GTIN 08714729975076;
EU Serial number RP005010, GTIN 08714729975151. |
Recalling Firm/ Manufacturer |
Boston Scientific Corporation 1 Scimed Pl Maple Grove MN 55311-1565
|
For Additional Information Contact | Ms. Rebecca KinKead Rubio 763-494-1133 |
Manufacturer Reason for Recall | Manufacturing instructions did not include the directions to not retest the pneumatic kit component of the ROTAPRO console upon failure, an internal nonconformity. |
FDA Determined Cause 2 | Employee error |
Action | The recalling firm issued letters dated 11/8/2021 on the same date and flagged "Urgent Medical Device Removal - Immediate Action Required." It explains the reason for recall, the risk to health, and provides removal instructions. The instructions say to immediately discontinue use of and segregate the affected product. A Reply Verification Tracking Form is enclosed for immediate completion and return. The customer will be contacted by BSC and provided a Returned Goods Authorization for return of the device. |
Quantity in Commerce | 7 devices |
Distribution | Worldwide distribution - US Nationwide distribution in the states of FL, NV, NY, OH, PA, and WA. The countries of Germany. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|